Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian ...
ROCKVILLE, MD, Nov. 15, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email